000 01384 a2200361 4500
005 20250516171951.0
264 0 _c20150107
008 201501s 0 0 eng d
022 _a1996-3181
024 7 _a10.2174/18715273113126660158
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSohrab, Sayed S
245 0 0 _aBacteriophage--a common divergent therapeutic approach for Alzheimer's disease and type II diabetes mellitus.
_h[electronic resource]
260 _bCNS & neurological disorders drug targets
_cApr 2014
300 _a491-500 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAlzheimer Disease
_ximmunology
650 0 4 _aAmyloid beta-Peptides
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aBacterial Infections
_xcomplications
650 0 4 _aBacteriophages
_xphysiology
650 0 4 _aDiabetes Mellitus, Type 2
_ximmunology
650 0 4 _aHumans
700 1 _aKarim, Sajjad
700 1 _aKamal, Mohammad A
700 1 _aAbuzenadah, Adel M
700 1 _aChaudhary, Adeel G
700 1 _aAl-Qahtani, Mohammed H
700 1 _aMirza, Zeenat
773 0 _tCNS & neurological disorders drug targets
_gvol. 13
_gno. 3
_gp. 491-500
856 4 0 _uhttps://doi.org/10.2174/18715273113126660158
_zAvailable from publisher's website
999 _c23110597
_d23110597